Clinical Trials

Showing trials with last updates posted in 2026.

NCT04181060 | RECRUITING | PHASE3
300 participants

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2020-12-28
Completion:
2026-12-31
Conditions
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
  • Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT03779854 | ACTIVE_NOT_RECRUITING | PHASE2
45 participants

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2019-08-29
Completion:
2028-12-31
Conditions
  • Acute Biphenotypic Leukemia
  • Acute Leukemia
  • Acute Leukemia of Ambiguous Lineage
  • Acute Lymphoblastic Leukemia
  • Acute Undifferentiated Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Blasts Under 25 Percent of Bone Marrow Nucleated Cells
  • Blasts Under 5 Percent of Bone Marrow Nucleated Cells
  • Mixed Phenotype Acute Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-1
  • Myelodysplastic Syndrome/Acute Myeloid Leukemia
  • Burkitt Leukemia
  • Chronic Monocytic Leukemia
  • Lymphoblastic Lymphoma
  • Mast Cell Leukemia
  • Myeloproliferative Neoplasm
Interventions
  • RADIATION
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page